Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
- PMID: 32241883
- PMCID: PMC7279186
- DOI: 10.1136/thoraxjnl-2019-213732
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
Abstract
There has been limited evidence for the association between chronic obstructive pulmonary disease (COPD) and the incidence of lung cancer among never smokers. We aimed to estimate the risk of lung cancer incidence in never smokers with COPD, and to compare it with the risk associated with smoking. This cohort study involved 338 548 subjects, 40 to 84 years of age with no history of lung cancer at baseline, enrolled in the National Health Insurance Service National Sample Cohort. During 2 355 005 person-years of follow-up (median follow-up 7.0 years), 1834 participants developed lung cancer. Compared with never smokers without COPD, the fully-adjusted hazard ratios (95% CI) for lung cancer in never smokers with COPD, ever smokers without COPD, and ever smokers with COPD were 2.67 (2.09 to 3.40), 1.97 (1.75 to 2.21), and 6.19 (5.04 to 7.61), respectively. In this large national cohort study, COPD was also a strong independent risk factor for lung cancer incidence in never smokers, implying that COPD patients are at high risk of lung cancer, irrespective of smoking status.
Keywords: COPD; lung cancer; never smokers.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea.BMC Pulm Med. 2020 Jun 15;20(1):170. doi: 10.1186/s12890-020-01194-8. BMC Pulm Med. 2020. PMID: 32539764 Free PMC article.
-
Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea.Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:2037-2046. doi: 10.2147/COPD.S213665. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31564851 Free PMC article.
-
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.Int J Chron Obstruct Pulmon Dis. 2019 May 1;14:929-938. doi: 10.2147/COPD.S190244. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31118602 Free PMC article.
-
Mechanisms involved in lung cancer development in COPD.Int J Biochem Cell Biol. 2011 Jul;43(7):1030-44. doi: 10.1016/j.biocel.2010.08.022. Epub 2010 Oct 14. Int J Biochem Cell Biol. 2011. PMID: 20951226 Review.
-
Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment.Lancet Respir Med. 2022 May;10(5):497-511. doi: 10.1016/S2213-2600(21)00506-3. Epub 2022 Apr 12. Lancet Respir Med. 2022. PMID: 35427530 Review.
Cited by
-
Efficacy and safety of radial probe endobronchial ultrasound-guided biopsy for peripheral lung lesions in chronic obstructive pulmonary disease patients.Transl Lung Cancer Res. 2024 Oct 31;13(10):2500-2510. doi: 10.21037/tlcr-24-484. Epub 2024 Oct 25. Transl Lung Cancer Res. 2024. PMID: 39507045 Free PMC article.
-
Association of moderate-to-vigorous physical activity with reduction of acute exacerbation in COPD patients using a dual ultra-long-acting bronchodilators.Sci Rep. 2024 Nov 2;14(1):26440. doi: 10.1038/s41598-024-75702-9. Sci Rep. 2024. PMID: 39488629 Free PMC article.
-
Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease.Respir Res. 2024 Sep 9;25(1):333. doi: 10.1186/s12931-024-02963-3. Respir Res. 2024. PMID: 39252048 Free PMC article.
-
Prevalence of and factors associated with likely obstructive sleep apnea in individuals with airflow limitation.Front Med (Lausanne). 2024 Jul 9;11:1343372. doi: 10.3389/fmed.2024.1343372. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39045412 Free PMC article.
-
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy.Acta Pharm Sin B. 2024 Jul;14(7):2901-2926. doi: 10.1016/j.apsb.2024.03.006. Epub 2024 Mar 11. Acta Pharm Sin B. 2024. PMID: 39027258 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical